Juridische, Financiële En Organisatorische Aspecten Van De Gezondheidszorg
Institution
Universiteit Gent (UGent)
Book
Rechtspraak en wetgevingsbundel gezondheidsrecht
Volledige samenvatting + lesnota's + inhoud van alle ppt-slides.
Lessen van prof. dr. Eecklo en prof. dr. Balthazar - 2020
Voorbeeldexamenvragen bijgevoegd
Geslaagd in eerste zit met deze samenvatting !
8.1. ORGANIZE INTO INTEGRATED PRACTICE UNITS ........................................................................................................ 14
8.2. MEASURE OUTCOMES AND COSTS FOR EVERY PATIENT ............................................................................................. 14
8.3. MOVE TO BUNDLED PAYMENT FOR CARE CYCLES ..................................................................................................... 14
8.4. INTEGRATE CARE DELIVERY ACROSS SEPARATE FACILITIES .......................................................................................... 14
8.5. EXPAND EXCELLENT SERVICES ACROSS GEOGRAPHY.................................................................................................. 14
8.6. BUILD AN ANABLING INFORMATION TECHNOLOGY PLATFORM .................................................................................... 14
DEEL II: PROF. DR. BALTHAZAR - PATIËNTENRECHTEN ........................................................................................... 15
9. WET PATIËNTENRECHTEN – WET 22 AUGUSTUS 2002..................................................................................... 15
9.1. (HISTORISCHE) BEDOELINGEN VAN DE WET............................................................................................................ 15
9.2. BREED TOEPASSINGSGEBIED ............................................................................................................................... 15
9.3. NALEVINGSPLICHT EN ‘MEDEWERKINGSPLICHT’ ...................................................................................................... 15
9.4. OVERZICHT GEWAARBORGDE RECHTEN ................................................................................................................. 15
RECHT OP KWALITEITSVOLLE DIENSTVERLENING – ART.5 ........................................................................................................... 15
RECHT OP VRIJE KEUZE – ART.6............................................................................................................................................. 16
RECHT OP INFORMATIE – ART.7 ............................................................................................................................................ 16
RECHT OP TOESTEMMING – ART.8 ........................................................................................................................................ 17
RECHT OP INZAGE IN DOSSIER – ART.9 ................................................................................................................................... 17
RECHT OP EERBIEDIGING VAN PERSOONLIJKE LEVENSSFEER – ART.10 ........................................................................................... 18
RECHT OP KLACHTENBEMIDDELING – ART.11 .......................................................................................................................... 18
RECHT OP PALLIATIEVE ZORG – ART.11 BIS ............................................................................................................................. 18
9.5. VERTEGENWOORDIGING VAN DE PATIËNT ............................................................................................................. 19
MINDERJARIGEN IN PATIËNTENRECHTENWET .......................................................................................................................... 19
VERTEGENWOORDIGING VAN PERSONEN ONDER BESCHERMINGSSTATUUT ................................................................................... 20
UITZONDERINGEN OP RECHTEN VAN VERTEGENWOORDIGERS..................................................................................................... 21
10. REGULERING VAN DE BEROEPSUITOEFENING ............................................................................................... 22
10.1. MOGELIJKE NIVEAUS VAN NORMERING VAN BEROEPSUITOEFENING........................................................................... 22
10.2. MOGELIJKE VORMEN VAN REGULERING .............................................................................................................. 22
10.3. WET UITOEFENING GEZONDHEIDSZORGBEROEPEN ................................................................................................. 22
WET VAN 10 MEI 2015: ‘GECOÖRDINEERDE WET BETREFFENDE DE UITOEFENING VAN DE GEZONDHEIDSZORGBEROEPEN’ ................... 22
GRONDIGE HERVORMING KB 78 (VOORGESTELD DOOR REGEERAKKOORD MICHEL I): 28 SEPTEMBER 2016: ..................................... 23
GEREGELDE BEROEPEN IN HUIDIGE WUG (KB 78) ................................................................................................................... 23
UITOEFENING GENEESKUNDE ............................................................................................................................................... 24
ONWETTIGE UITOEFENING VAN DE GENEESKUNDE.................................................................................................................... 25
NIET CONVENTIONELE GENEESWIJZEN .................................................................................................................................... 25
UITOEFENING VAN DE TANDHEELKUNDE ................................................................................................................................. 25
VROEDVROUWKUNDE ......................................................................................................................................................... 25
DE ARTSENIJBEREIDKUNDE ................................................................................................................................................... 26
DE KINESITHERAPIE ............................................................................................................................................................. 26
DE VERPLEEGKUNDE ........................................................................................................................................................... 27
VERPLEEGKUNDIG SPECIALIST ............................................................................................................................................... 27
MANTELZORG ................................................................................................................................................................... 27
ZORGKUNDIGE ................................................................................................................................................................... 27
AMBULANCIER-HULPVERLENER ............................................................................................................................................. 27
PARAMEDISCHE BEROEPEN .................................................................................................................................................. 28
GEESTELIJKE GEZONDHEIDSZORGBEROEPEN: PSYCHOLOGEN, KLINISCH PSYCHOLOGEN EN PSYCHOTHERAPEUTEN ................................. 28
3
,11. DE KRACHTLIJNEN VAN DE KWALITEITSWET ................................................................................................. 29
11.1. KWALITEITSWET – 22 APRIL 2019 ..................................................................................................................... 29
UNIFORME TOEPASSING VAN DE KWALITEITSVEREISTEN............................................................................................................. 29
11.2. BEKWAAMHEID EN VISUM ............................................................................................................................... 30
11.3. BEGINSEL VAN THERAPEUTISCHE VRIJHEID ........................................................................................................... 30
SANCTIONEREN VAN SCHENDING VAN THERAPEUTISCHE VRIJHEID ............................................................................................... 31
11.4. VOORBEHOUDEN PRESCRIPTIERECHT .................................................................................................................. 31
11.5. DE NIEUWE KARAKTERISATIEVERPLICHTING.......................................................................................................... 31
MOGELIJKE GEVOLGEN VAN DE KARAKTERISATIE ...................................................................................................................... 31
11.6. 3 TYPE VOORSCHRIFTEN .................................................................................................................................. 32
VOORSCHRIFT VOOR GENEESMIDDELEN OF GEZONDHEIDSPRODUCTEN ......................................................................................... 32
VERWIJSVOORSCHRIFT ........................................................................................................................................................ 32
GROEPSVOORSCHRIFT ......................................................................................................................................................... 32
11.7. PERMANENTIE .............................................................................................................................................. 33
11.8. REGELING OVER PRAKTIJKINFORMATIE (SOMS BESCHOUWD ALS PUBLICITEIT/WERVENDE RECLAME) ................................ 33
11.9. PATIËNTENDOSSIER ........................................................................................................................................ 33
11.10. TOEGANG TOT GEZONDHEIDSGEGEVENS ............................................................................................................ 33
11.11. NIEUWE SANCTIE REGELING ............................................................................................................................ 34
11.12. TOEZICHT ................................................................................................................................................... 34
12. DE WETGEVING BETREFFENDE ZWANGERSCHAPSAFBREKING ...................................................................... 35
12.1. HISTORIEK .................................................................................................................................................... 35
12.2. VOORWAARDEN VOOR NIET-STRAFBARE ZWANGERSCHAPSAFBREKING ...................................................................... 35
12.3. VERPLICHTINGEN VAN DE ARTS ......................................................................................................................... 36
12.4. WACHTTIJD EN BEVESTIGING ............................................................................................................................ 36
12.5. UITZONDERINGSREGEL .................................................................................................................................... 36
12.6. COMPLEXE DISCUSSIE OVER ZWANGERSCHAPSAFBREKING IN DERDE TRIMESTER ........................................................... 37
12.7. GEWETENSVRIJHEID EN VOORLICHTINGSPLICHT..................................................................................................... 37
13. JURIDISCHE REACTIES OP PSYCHISCHE PROBLEMEN EN STOORNISSEN: GEDWONGEN OPNAME EN
BEHANDELING ....................................................................................................................................................... 38
13.1. AANTASTING VAN VERMOGEN OM DEEL TE NEMEN AAN RECHTSVERKEER ................................................................... 38
IMPLICATIES VAN TIJDELIJKE OF PERMANENTE PSYCHISCHE STOORNISSEN OP VERMOGEN OM DEEL TE NEMEN AAN HET RECHTSVERKEER . 38
‘BESCHERMINGSMAATREGELEN’ BIJ (DREIGEND) DEVIANT EN GEVAARLIJK GEDRAG DAT NIET STRAFBAAR IS OF NIET STRAFRECHTELIJK
VERVOLGD WORDT ............................................................................................................................................................. 38
SPECIFIEKE REACTIE OP STRAFBARE HANDELINGEN.................................................................................................................... 38
DEEL 1: REGELINGEN BIJ ONVERMOGEN OM (VOLWAARDIG) DEEL TE NEMEN AAN RECHTSVERKEER:............................................. 39
13.2. BIJSTAND, BESCHERMING EN VERTEGENWOORDIGING VAN VOLWASSEN ONBEKWAMEN – WET 17/03/2013 ................... 39
13.3. DRIE KRACHTLIJNEN VAN DE WET....................................................................................................................... 39
13.4. BUITENGERECHTELIJKE BESCHERMING – ‘ZORGVOLMACHT’ ..................................................................................... 40
13.5. GERECHTELIJKE BESCHERMING .......................................................................................................................... 40
13.6. BEWINDVOERDER .......................................................................................................................................... 40
13.7. ‘HOOGSTPERSOONLIJKE’ HANDELINGEN .............................................................................................................. 40
BASISBESCHIKKING EN HANDELINGEN OVER PERSOON ............................................................................................................... 41
BASISBESCHIKKING EN HANDELINGEN IN VERBAND MET GOEDEREN ............................................................................................. 41
13.8. VERTROUWENSPERSOON IN WET VAN 2013 ........................................................................................................ 41
13.9. UITOEFENING VAN PATIËNTENRECHTEN .............................................................................................................. 41
DEEL 2: GEDWONGEN OPNEMING ................................................................................................................................. 42
13.10. ALGEMENE PRINCIPES ................................................................................................................................... 42
13.11. CRITERIUM VOOR BESCHERMINGSMAATREGELEN ................................................................................................ 42
MAATREGELEN IN TIJDSLIJN.................................................................................................................................................. 43
4
, 13.12. PROCEDURES VOOR OPNEMING TER OBSERVATIE ................................................................................................ 43
MODALITEITEN EN DUUR VAN INOBSERVATIESTELLING .............................................................................................................. 44
13.13. VERDER VERBLIJF ......................................................................................................................................... 45
13.14. GEDWONGEN BEHANDELING ? ........................................................................................................................ 45
14. AANSPRAKELIJKHEID IN DE GEZONDHEIDSZORG .......................................................................................... 46
14.1. MOGELIJKE FOUTEN EN NALATIGHEDEN .............................................................................................................. 46
14.2. DRIE VORMEN VAN AANSPRAKELIJKHEID ............................................................................................................. 46
CIVIELRECHTELIJKE AANSPRAKELIJKHEID.................................................................................................................................. 47
STRAFRECHTELIJKE AANSPRAKELIJKHEID.................................................................................................................................. 47
TUCHTRECHTELIJKE AANSPRAKELIJKHEID ................................................................................................................................. 47
CUMULATIE....................................................................................................................................................................... 47
14.3. EVOLUTIE NAAR FOUTINDEFFERENTE AANSPRAKELIJKHEID ....................................................................................... 47
14.4. KERN VAN BEIDE SYSTEMEN ............................................................................................................................. 48
14.5. FOUTAANSPRAKELIJKHEID TOEGEPAST IN GEZONDHEIDSZORG .................................................................................. 48
3 BASISVOORWAARDEN VOOR AANSPRAKELIJKHEID .................................................................................................................. 48
HET FOUTBEGRIP................................................................................................................................................................ 48
14.6. OMSTANDIGHEDEN KUNNEN OOK LEIDEN TOT AANSPRAKELIJKHEID VAN ZIEKENHUIS (ALS INSTELLING).............................. 50
BELANG ALS ORGANISATIE ................................................................................................................................................... 50
14.7. CONCRETISERING VAN HET FOUTBEGRIP IN ‘ZORGVULDIGHEIDSNORMEN’ ................................................................... 51
14.8. GROEIEND BELANG VAN INFORMATIE EN TOESTEMMING......................................................................................... 52
OMVANG VAN INFORMATIEPLICHT ........................................................................................................................................ 52
VORM VAN DE TOESTEMMING .............................................................................................................................................. 53
14.9. PROCEDURES BIJ FOUT OF ONZORGVULDIGHEID .................................................................................................... 53
MINNELIJK (=SCHADEVERGOEDING) ...................................................................................................................................... 53
STRAFRECHTELIJK ............................................................................................................................................................... 53
CIVIELRECHTELIJK ............................................................................................................................................................... 54
TUCHTRECHTELIJK .............................................................................................................................................................. 54
14.10. VERZEKERING.............................................................................................................................................. 54
INHOUD POLIS ................................................................................................................................................................... 55
VERPLICHTING VAN DE VERZEKERDE....................................................................................................................................... 55
14.11. STELSEL NA UITVOERING VAN WET 31 MAART 2010 ............................................................................................ 56
14.12. FONDS VOOR MEDISCHE ONGEVALLEN .............................................................................................................. 56
WAT IS ERNSTIGE SCHADE? .................................................................................................................................................. 56
WAT IS EEN MOZA? .......................................................................................................................................................... 57
WORDEN NIET VERGOED DOOR HET FONDS ............................................................................................................................ 58
PROCEDURE FONDS ............................................................................................................................................................ 58
15.1. TECHNIEKEN MEDISCH BEGELEIGE VOORTPLANTING .............................................................................................. 59
INTRAUTERIENE INSEMINATIE ............................................................................................................................................... 59
KUNSTMATIGE INSEMINATIE................................................................................................................................................. 59
IN VITRO FERTILISATIE ......................................................................................................................................................... 59
INTRA-CYTOPLASMATISCHE SPERMA-INJECTIE (ICSI)................................................................................................................. 60
PRE-IMPLANTATIE-DIAGNOSE (PID) ...................................................................................................................................... 60
KLONEREN ........................................................................................................................................................................ 60
CRISPR-CAS-9 ................................................................................................................................................................... 60
15.2. ETHISCHE EN JURIDISCHE DILEMMA’S ................................................................................................................. 61
15.3. ACTUEEL JURIDISCH KADER............................................................................................................................... 61
15.4. WET VAN 11 MEI 2003 BETREFFENDE ONDERZOEK OM EMBRYO’S IN VITRO ............................................................... 62
WANNEER IS ONDERZOEK OP EMBRYO’S GEOORLOOFD? ........................................................................................................... 62
VERBODEN ‘ONTSPORINGEN’ ............................................................................................................................................... 62
TOESTEMMING VAN DONOREN ............................................................................................................................................. 62
5
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller MBGZHZ. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $15.72. You're not tied to anything after your purchase.
